What caused the PRFN.SW stock move today?

The pre-market drop to **CHF0.0362** and **-8.12%** appears driven by heavy selling and volume of **2,937,350** shares. No public earnings release was posted, so traders are likely reacting to liquidity and sentiment rather than a specific company report.

What is the Meyka AI outlook for PRFN.SW stock?

Meyka AI's forecast model projects a 12-month target of **CHF0.08**, implying about **121.00%** upside from **CHF0.0362**. This model-based projection is not a guarantee and depends on clinical and financing developments.

Is PRFN.SW stock suitable for long-term investors?

PRFN.SW is a small clinical-stage name with negative EPS and limited publicly reported capital metrics. Long-term suitability depends on risk tolerance, clinical progress, and access to financing. The Meyka grade is **B (HOLD)**, not a recommendation.

How liquid is PRFN.SW stock on SIX?

Pre-market volume on 13 Feb 2026 reached **2,937,350** against an average of **859,130**, giving a relative volume near **3.42**. Liquidity can spike but also dry quickly, increasing execution risk for large orders.

CH Stocks

PRFN.SW Kinarus (SIX) pre-market 13 Feb 2026: -8.12% to CHF0.0362, high volume signal

ByHuzaifa Zahoor February 13, 2026February 13, 2026

PRFN.SW stock opened weaker in pre-market trading on 13 Feb 2026 after a sharp intraday move. The share price is CHF0.0362, down -8.12% from the previous close, with 2,937,350 shares trading so far. This spike in activity leaves PRFN.SW among the most active names on the SIX pre-market tape and raises short-term volatility. We assess what the volume, valuation and sector signals mean for traders and longer-term investors.